key: cord-0906254-neglgx5x authors: Sarode, Sachin C.; Sarode, Gargi S.; Sengupta, Namrata; Kumar Sharma, Nilesh; Patil, Shankargouda title: Biological behavior of oral squamous cell carcinoma in the background of novel corona virus infection date: 2020-05-07 journal: Oral Oncol DOI: 10.1016/j.oraloncology.2020.104781 sha: f0b78cc0ffd4e3167795e2124ab84ead6fd539c6 doc_id: 906254 cord_uid: neglgx5x nan Recent studies on Covid19 have indicated that the path of entry of 2019-nCov into a host cell is through the ACE2 cell receptor. 4 The virus attaches itself to this receptor through the Sspike present on the virus surface. 5 ACE2 has been identified as the co-receptor for the corona virus. Intriguingly, ACE2 receptor of this virus is highly expressed on the oral mucosal epithelial cells. 6 The single cell RNA sequence of four samples of oral mucosal tissues were observed and the expression of ACE2 was recorded higher in epithelial cells of tongue than buccal and gingival tissues. 6 The virus expresses a protein, which is known as SPIKE (S protein). This protein contains a receptor binding region, which attaches to the extracellular part of the ACE2. The S protein is broken down into two subunits-S1 and S2 by a host protease TMPRSS2. 6 The virus fuses with the membrane and is incorporated via endocytosis with ACE2 into the host cell. Thus, COVID-19 infection causes exhaustion of ACE2 cell receptors. In situations of COVID-19 infection in OSCC patients, there will be reduction in availability of ACE2. This situation will increases the concentration of Ang II, thus could be promoting a pro-tumoral effect mediated by Ang II. Exposure to tobacco has always been regarded as a vital risk factor for the development of Angiotensin converting enzyme inhibitors (ACEIs) and Angiotensin receptor blockers (ARBs) are quite known to be used as treatment regime in carcinoma patients to manage hypertension. 8 The production of Ang II is inhibited by ACEIs and thus subsequently the pro- This hypothesis needs to be addressed. Moreover, it is still a matter of concern whether or not to use these medications for patients in this pandemic condition. Molecular biology of oral cavity squamous cell carcinoma Angiotensin 1-7 inhibits angiotensin II-stimulated head and neck cancer progression Angiotensin-converting enzyme 2 (ACE2) in disease pathogenesis SARS and MERS: recent insights into emerging coronaviruses Physiological and pathological regulation of ACE2, the SARS-CoV-2 receptor High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa Tobacco Smoking Increases the Lung Gene Expression of ACE2, the Receptor of SARS-CoV-2 The angiotensin receptor blocker, Losartan, inhibits mammary tumor development and progression to invasive carcinoma COVID-19 and RAS: Unravelling an Unclear Relationship Funding source: None declared.